BFC Planning’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BFC Planning's ANGO Position: Q3 2026 in Review
BFC Planning sold out of AngioDynamics (ANGO) in Q3 2026, closing a stake of 500 shares — an estimated $6.5K sold.
BFC Planning first reported a position in ANGO in Q3 2025 and held it in 4 quarters. The position peaked at $6.5K in Q2 2026. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.
- BFC Planning reported no remaining AngioDynamics position as of Q3 2026 after selling out during the quarter.
- BFC Planning sold 500 AngioDynamics shares in Q3 2026, an estimated $6.5K.
- BFC Planning first reported a position in AngioDynamics in Q3 2025 and held it in 4 quarters.
- BFC Planning's AngioDynamics position peaked at $6.5K in Q2 2026.
- 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.